Panelists discuss how pharmacists can identify high-risk adults for severe RSV—such as those with chronic conditions or advanced age—by reviewing medication profiles, and how they can overcome barriers like limited awareness and workflow challenges to drive vaccine uptake through education, accessibility, and recent policy-supported coverage.